Evidence-Based And Value-Based Formulary Guidelines
- 1 January 2004
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 23 (1), 124-134
- https://doi.org/10.1377/hlthaff.23.1.124
Abstract
Health plans and hospitals have long used drug formularies, but the processes by which formulary committees made decisions have typically lacked transparency and scientific rigor. A growing number ...Keywords
This publication has 12 references indexed in Scilit:
- Economic Messages in Prescription Drug Advertisements in Medical JournalsMedical Care, 2002
- ANTIPODEAN ASSESSMENTInternational Journal of Technology Assessment in Health Care, 2002
- Funding medicines for people with multiple sclerosisBMJ, 2001
- Decision-makers′ use of pharmacoeconomics: what does the research tell us?Expert Review of Pharmacoeconomics & Outcomes Research, 2001
- AMCP Guidance for Submission of Clinical and Economic Evaluation Data to Support Formulary Listing in U.S. Health Plans and Pharmacy Benefits Management OrganizationsJournal of Managed Care Pharmacy, 2001
- Health Economic Guidelines—Similarities, Differences and Some ImplicationsValue in Health, 2001
- The failings of NICEBMJ, 2001
- Emerging role of pharmacoeconomics in the research and development decision-making process.PharmacoEconomics, 2001
- Using Economic Evaluations to Make Formulary Coverage DecisionsPharmacoEconomics, 2000
- Oregon's Bold Experiment: Whatever Happened to Rationing?Journal of Health Politics, Policy and Law, 1999